EA201171368A1 - Новые гетероциклические соединения - Google Patents

Новые гетероциклические соединения

Info

Publication number
EA201171368A1
EA201171368A1 EA201171368A EA201171368A EA201171368A1 EA 201171368 A1 EA201171368 A1 EA 201171368A1 EA 201171368 A EA201171368 A EA 201171368A EA 201171368 A EA201171368 A EA 201171368A EA 201171368 A1 EA201171368 A1 EA 201171368A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compounds
heterocyclic compounds
accumulation
age
formation
Prior art date
Application number
EA201171368A
Other languages
English (en)
Inventor
Чхайтанья Дутт
Виджай Чхаутхайвале
Рамеш Чхандра Гупта
Маниш Пател
Джигнеш Котечха
Сачхин Латад
Джая Абрахам
Санджай Сривастава
Милинд Роде
Шайлеш Дешпанде
Анита Чхаудхари
Амит Кумар Кесарвани
Original Assignee
Торрент Фармасьютикалз Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Торрент Фармасьютикалз Лимитед filed Critical Торрент Фармасьютикалз Лимитед
Publication of EA201171368A1 publication Critical patent/EA201171368A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Abstract

Данное изобретение относится к новому классу гетероциклических соединений и их фармацевтически приемлемых солей, к способу их получения, фармацевтической композиции, содержащей эти соединения, и к их применению при лечении заболеваний, вызванных образованием и накоплением AGE (конечные продукты гликации). Соединения данного изобретения применимы для лечения диабетических и связанных с возрастом осложнений, вызванных образованием и накоплением AGE, таких как невропатия, нефропатия, микроангиопатия, ретинопатия, гипертензия, сердечная недостаточность, атеросклероз, болезнь Альцгеймера и дерматологические нарушения.
EA201171368A 2009-05-07 2010-05-06 Новые гетероциклические соединения EA201171368A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1207MU2009 2009-05-07
PCT/IN2010/000295 WO2010128528A2 (en) 2009-05-07 2010-05-06 Novel heterocyclic compounds

Publications (1)

Publication Number Publication Date
EA201171368A1 true EA201171368A1 (ru) 2012-04-30

Family

ID=42937397

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201171368A EA201171368A1 (ru) 2009-05-07 2010-05-06 Новые гетероциклические соединения

Country Status (16)

Country Link
US (1) US20120046317A1 (ru)
EP (1) EP2427432A2 (ru)
JP (1) JP2012526103A (ru)
KR (1) KR20120018185A (ru)
CN (1) CN102459175A (ru)
AR (1) AR080267A1 (ru)
AU (1) AU2010245596A1 (ru)
BR (1) BRPI1006611A2 (ru)
CA (1) CA2764232A1 (ru)
EA (1) EA201171368A1 (ru)
IL (1) IL216092A0 (ru)
MX (1) MX2011011650A (ru)
SG (1) SG175422A1 (ru)
TW (1) TW201102380A (ru)
WO (1) WO2010128528A2 (ru)
ZA (1) ZA201108702B (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104744351B (zh) * 2014-09-30 2017-06-06 三峡大学 一种小分子抑制剂及在抑制鸟氨酸脱羧酶(odc)上的应用
SG11201708142XA (en) * 2015-04-08 2017-11-29 Torrent Pharmaceuticals Ltd Pharmaceutical formulations

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4758583A (en) 1984-03-19 1988-07-19 The Rockefeller University Method and agents for inhibiting protein aging
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
JPH08502508A (ja) * 1992-10-23 1996-03-19 メルク シヤープ エンド ドーム リミテツド ドーパミンレセプターサブタイプリガンド
US5656261A (en) 1995-01-18 1997-08-12 The Picower Institute For Medical Research Preventing and reversing advanced glycosylation endproducts
JP4067562B2 (ja) 1995-01-18 2008-03-26 アルテオン インコーポレイテッド 進行性グリコシル化最終生成物の生成を阻止し、反転するためのチアゾリウム化合物の使用
CZ291789B6 (cs) 1999-10-06 2003-05-14 Torrent Pharmaceuticals Ltd Pyridiniová sloučenina, způsob její výroby, její použití, farmaceutický prostředek ji obsahující a jeho použití
HUP0301687A2 (hu) 1999-10-06 2003-08-28 Torrent Pharmaceuticals Ltd. Cukorbetegséggel és öregedéssel kapcsolatos érrendszeri szövődmények kezelésére szolgáló piridinium-vegyületek és eljárás az előállításukra
DK1243581T3 (da) * 2001-03-21 2005-10-31 Torrent Pharmaceuticals Ltd Pyridiniumforbindelser til behandling af AGE-relaterede sygdomme
JP4485744B2 (ja) 2001-04-05 2010-06-23 トレント・ファーマシューティカルズ・リミテッド 老化−関連及び糖尿病性血管性合併症のための複素環式化合物
HUP0104832A2 (en) * 2001-10-19 2003-08-28 Torrent Pharmaceuticals Ltd Cosmetic composition and method
KR100437972B1 (ko) * 2001-10-27 2004-07-02 한국과학기술연구원 피롤리디논 유도체, 이의 제조 방법 및 이를 포함하는제약 조성물
EP2150543A2 (en) * 2007-04-24 2010-02-10 Solvay Pharmaceuticals B.V. Heterocyclic compounds with affinity to muscarinic receptors

Also Published As

Publication number Publication date
WO2010128528A3 (en) 2010-12-23
IL216092A0 (en) 2012-01-31
MX2011011650A (es) 2012-02-21
CN102459175A (zh) 2012-05-16
AU2010245596A1 (en) 2011-12-22
TW201102380A (en) 2011-01-16
ZA201108702B (en) 2012-09-26
KR20120018185A (ko) 2012-02-29
CA2764232A1 (en) 2010-11-11
US20120046317A1 (en) 2012-02-23
WO2010128528A2 (en) 2010-11-11
BRPI1006611A2 (pt) 2016-04-19
WO2010128528A9 (en) 2011-03-03
SG175422A1 (en) 2011-11-28
EP2427432A2 (en) 2012-03-14
JP2012526103A (ja) 2012-10-25
AR080267A1 (es) 2012-03-28

Similar Documents

Publication Publication Date Title
EA201071045A1 (ru) Соединения оксадиазоантрацена для лечения диабета
UA113051C2 (xx) Гетероциклічні похідні та їх застосування у лікуванні неврологічних розладів
EA201071298A1 (ru) Соединение 3-аминокарбазола, фармацевтическая композиция, его содержащая, и способ их получения
EA201391029A1 (ru) Производные оксазина и их применение при лечении неврологических нарушений
IN2014DN03206A (ru)
BR112014012815A8 (pt) derivados de trifluormetil-oxadiazol e uso dos mesmos no tratamento de doença
EA201171197A1 (ru) Замещенные производные азоантрацена, фармацевтические композиции и способы их применения
EA201170705A1 (ru) Арилметилбензохиназолиноны в качестве позитивных аллостерических модуляторов рецептора м1
EA201200686A1 (ru) Новые терапевтические подходы для лечения болезни альцгеймера
CY1112429T1 (el) Υποκατεστημενα παραγωγα σουλφοναμιδιου
EA200970611A1 (ru) Замещенные пиразолохиназолиновые производные, способ их получения и их применение в качестве ингибиторов киназы
ECSP10010226A (es) Compuestos derivados de amina para tratar enfermedades y trastornos oftálmicos
EA201100423A1 (ru) Новые бензамиды, их получение и их применение в качестве лекарственных средств
NO20082124L (no) Bifenyloksyeddiksyrederivater for behandling av respiratorisk sykdom
EA201490888A1 (ru) Новые производные пурина и их применение для лечения заболевания
UA104489C2 (ru) Соединения для лечения дислипидемии и родственных болезней
EA200971107A1 (ru) Катехоламиновые производные, полезные для лечения болезни паркинсона
EA201300250A1 (ru) Оксадиазольные ингибиторы продуцирования лейкотриена
EA201390984A1 (ru) Гетероциклические соединения, подходящие для лечения дислипидемии
EA200971086A1 (ru) Фармацевтические композиции и способ лечения шизофрении
EA201490630A1 (ru) 6-замещенные 3-(хинолин-6-илтио)[1,2,4]триазоло[4,3-a]пиридины в качестве ингибиторов c-met тирозинкиназы
NZ601508A (en) Substituted naphthalenyl-pyrimidine compounds and the use thereof in the treatment of cancer
EA201391026A1 (ru) Кристаллическое производное оксазина и его применение в качестве ингибитора bace
NO20081681L (no) N-[1,3,4]-tiadiazol-2-yl-benzensulfonamider, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytika
MX2013003202A (es) Inhibidores de oxadiazol de la produccion de leucotrienos.